Other gonococcal eye infection
ICD-10 A54.39 is a billable code used to indicate a diagnosis of other gonococcal eye infection.
Other gonococcal eye infections are caused by the bacterium Neisseria gonorrhoeae, which primarily affects the mucous membranes. These infections can manifest as conjunctivitis, keratitis, or other ocular complications. Gonococcal conjunctivitis is particularly concerning in neonates, as it can lead to severe complications, including corneal scarring and blindness if not treated promptly. In adults, the infection may occur due to direct contact with infected genital secretions, often during sexual activity. Symptoms typically include redness, swelling, discharge, and pain in the affected eye. Diagnosis is confirmed through culture or nucleic acid amplification tests (NAAT) from conjunctival swabs. Treatment involves systemic antibiotics, with ceftriaxone being the first-line therapy. It is crucial to also treat any sexual partners to prevent reinfection and further transmission. Contact tracing is essential in managing gonococcal infections, as it helps identify and treat individuals who may be asymptomatic carriers, thereby reducing the spread of the infection.
Detailed ocular examination findings, including visual acuity and specific symptoms.
Patients presenting with conjunctivitis, especially in sexually active individuals.
Documentation should clearly indicate the causative organism and any associated systemic symptoms.
Comprehensive sexual history and details of any co-infections.
Patients with multiple STIs or those requiring contact tracing.
Emphasis on partner notification and treatment adherence.
Used for follow-up visits after initial diagnosis and treatment of gonococcal eye infection.
Document the patient's history, examination findings, and treatment plan.
Ophthalmologists should include specific ocular findings.
Common symptoms include redness, swelling, discharge, and pain in the affected eye. In neonates, it can present as conjunctivitis shortly after birth.
Diagnosis is typically made through clinical examination and confirmed with laboratory tests such as culture or nucleic acid amplification tests (NAAT).
The first-line treatment is usually a single dose of ceftriaxone, along with treatment for any co-existing STIs.
Contact tracing helps identify and treat sexual partners, reducing the risk of reinfection and further transmission of the disease.
